Performance & GH axis

GHRP-6

Growth Hormone Releasing Peptide 6

Research compoundEvidence: Early human dataPeptideLimited human data

One of the original growth hormone secretagogues. Strongly stimulates growth hormone release and is known for significantly increasing appetite — sometimes used specifically for that purpose.

Also known as: Growth Hormone Releasing Peptide-6, GHRP6

Status
GHRP-6 is a research compound and not approved by the FDA for human use.
Evidence
Early human data. Only small or early-phase studies in people so far.
Half-life
~15-60 minutes
How it's taken
Subcutaneous injection, 2-3x daily
Mechanism
Growth-hormone secretagogue
Pathways
GH-releasing peptide, GH axis

How GHRP-6 works

Binds to the ghrelin receptor in the pituitary gland, triggering a powerful burst of growth hormone. Also stimulates appetite through the same ghrelin pathway, which can be a benefit or side effect depending on goals.

What research has looked at

Evidence level: Early human data. Only small or early-phase studies in people so far. These are areas studied or reported, not promised effects.

Reported side effects and risks

Sources

  1. PubMed research on GHRP-6 growth hormone releasing peptide 6 · NIH · National Library of Medicine
  2. DrugBank record for GHRP-6 · DrugBank
  3. Active clinical trials for GHRP-6 · U.S. National Library of Medicine

Track GHRP-6 in Peptide Vault

Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.

Get Peptide Vault

Related compounds

GHRP-6 FAQ

What is GHRP-6?

One of the original growth hormone secretagogues. Strongly stimulates growth hormone release and is known for significantly increasing appetite — sometimes used specifically for that purpose.

How does GHRP-6 work?

Binds to the ghrelin receptor in the pituitary gland, triggering a powerful burst of growth hormone. Also stimulates appetite through the same ghrelin pathway, which can be a benefit or side effect depending on goals.

Is GHRP-6 FDA approved?

No. GHRP-6 is a research compound and not approved by the FDA for human use. Evidence level: early human data. Only small or early-phase studies in people so far.

What is the half-life of GHRP-6?

Reported half-life: ~15-60 minutes.

How is GHRP-6 taken?

Subcutaneous injection, 2-3x daily.

What side effects have been reported with GHRP-6?

Reported in the sources: Intense hunger (very common); Water retention; Elevated cortisol and prolactin; Tingling and numbness; Potential blood sugar increase; Injection site irritation.

Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.